Innovative Solutions for Cell Therapy
Any cell Any site Any cancer
Our approach offers broad applicability across both approved and emerging CAR T therapies, with the potential to extend reach across diverse patient populations, therapeutic platforms, and clinical indications. In addition, our products are engineered for seamless integration with existing GMP-compliant manufacturing frameworks, presenting manufacturers a scalable and cost-efficient solution that minimizes the need for significant protocol modifications.
Empowering Cancer Care with Advanced Cell Therapy
Our mission is to develop transformative cell therapies for cancer cure through navigating therapeutic immune cells
​
​
​
Problem Statement
CAR T therapy has revolutionized the treatment landscape of blood cancers. However, challenges such as primary resistance and relapse are common. Current strategies aiming at enhancing the curative potential of CAR T therapy – such as promoting cell expansion, improving persistence, or acting on alternative targets – are deemed inadequate to address the multifactorial nature of treatment failure.
Competitive Edge
In addition, this novel approach of navigating CAR T cells to the bone marrow compartment is expected to be widely applicable to any blood cancers, thereby putting forward a universal solution to succeed the currently approved CAR modalities without target/disease restriction.
Cutting-Edge Universal Solutions
Our inventions focus on improving the initial events during CAR T therapy, thus seizing a completely new therapeutic angle to augment bone marrow homing, enable early tumor clearance and prevent overt relapses that are unique attributes distinctive from what have been built in the field.
Our Collaborative Network
Empower any immune cell to combat tumor cells at any site
Discover how our innovation can accelerate progress in a universal solution for advanced cell therapy.